|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Profit (loss) before tax | |||||
| Adjustments to reconcile net profit (loss) to net cash used in operating activities: | |||||
| Depreciation, amortization, impairment of non-current assets | |||||
| Equity settled share based payments | |||||
| Gain on disposal of investment in associate | |||||
| Fair value loss (gain) on revaluation | |||||
| Gain on disposal from PRV sale | |||||
| Loss (gain) on disposal of leases | |||||
| Other finance income | |||||
| Other finance expenses | |||||
| Share of net losses (gains) in associates using the equity method | |||||
| Other | |||||
| Operating cash flows before changes in working capital | |||||
| Changes in working capital: | |||||
| Inventories | |||||
| Trade and other receivables | |||||
| Payables and other current liabilities | |||||
| Provisions | |||||
| Restricted cash | |||||
| Total changes in working capital | |||||
| Interest received | |||||
| Income taxes received (paid) | |||||
| Net cash flows generated from (used in) operating activities | |||||
| Capital expenditure for property, plant and equipment | |||||
| Proceeds from PRV sale | |||||
| Investment intangible assets | |||||
| Disposal of investment designated as at FVOCI | |||||
| Proceed from sale of Investment associate | |||||
| Investment in equity instruments designated as at FVTOCI | |||||
| Acquisition of license | |||||
| Investment accounted for using the equity method | |||||
| Purchases of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Acquisition of a subsidiary, net of cash acquired | |||||
| Net cash flows generated from (used in) investing activities | |||||
| Payment on contingent consideration | |||||
| Payment of lease liabilities | |||||
| Interests on lease liabilities | |||||
| Net proceeds of issued convertible bonds | |||||
| Repurchase of convertible bonds | |||||
| Interests on convertible bonds | |||||
| Acquisition of non-controlling interests | |||||
| Exercise of share-based compensation awards | |||||
| Net cash flows generated from (used in) financing activities | |||||
| Increase (decrease) of cash | |||||
| Exchange rate effects | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...